I-4-(4-Aminophenoxy)-N-Methylpicolinamide CAS 284462-37-9 Sorafenib Tosylate Intermediate Factory High Purity
Ubonelelo ngezoRhwebo i-Sorafenib Tosylate kunye neziPhakathi eziNxulumeneyo:
I-Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
I-4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
I-4-(4-Aminophenoxy)-N-Methylpicolinamide CAS: 284462-37-9
I-4-Chloro-3-(Trifluoromethyl)phenyl Isocyanate CAS: 327-78-6
| Igama leMchiza | 4-(4-Aminophenoxy)-N-Methylpicolinamide |
| Izithethantonye | 4-(4-Aminophenoxy)-N-Methyl-2-Pyridinecarboxamide |
| Inombolo yeCAS | 284462-37-9 |
| Inombolo yeCAT | RF-PI166 |
| Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
| Ifomula yeemolekyuli | I-C13H13N3O2 |
| Ubunzima beMolekyuli | 243.27 |
| Indawo yokunyibilika | 110.0 ~ 112.0℃ |
| Ukuxinana | 1.241 g/cm3 |
| Uphawu | Ruifu Chemical |
| Into | Iinkcukacha |
| Imbonakalo | Umdaka oKhanyayo ukuya kwiPowder eMhlophe |
| Ubunyulu / Indlela yokuHlalutya | 98.0% ~ 101.0% (kwisiseko esomileyo) (HPLC) |
| Ilahleko ekomisweni | ≤0.50% |
| Intsalela kwi-Ignition | ≤0.20% |
| Ukungcola okukodwa | ≤0.20% |
| Ukungcola okupheleleyo | ≤1.0% |
| Iintsimbi ezinzima | ≤20ppm |
| Umgangatho woVavanyo | Umgangatho woShishino |
| Ukusetyenziswa | Umbindi weSorafenib Tosylate (CAS: 475207-59-1) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
Umenzi onobunyulu obuPhezulu kunye noMgangatho oZinzile
Ubonelelo ngezoRhwebo i-Sorafenib Tosylate (CAS: 475207-59-1) IziPhakathi eziNxulumeneyo:
I-Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
I-4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
I-4-(4-Aminophenoxy)-N-Methylpicolinamide CAS: 284462-37-9
I-4-Chloro-3-(Trifluoromethyl)phenyl Isocyanate CAS: 327-78-6
I-Sorafenib Tosylate (i-CAS: 475207-59-1) luhlobo olutsha lwechiza le-antitumor ekujoliswe kulo, laphuhliswa yi-German Bayer Pharmaceuticals, kwaye yabonisa umsebenzi owandayo we-antitumor kwiimvavanyo zezilwanyana zangaphambili.I-Sorafenib ifumaneka kwiipilisi ze-200-mg zolawulo lomlomo kwaye isetyenziselwa unyango lwe-RCC kunye ne-HCC.
